Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 43, Issue 11 (Nov 2005)

Issues

Reticulocyte hemoglobin measurement – comparison of two methods in the diagnosis of iron-restricted erythropoiesis

Lothar Thomas
  • Department of Laboratory Medicine, Krankenhaus Nordwest, Frankfurt am Main, Germany
/ Susanne Franck
  • Department of Laboratory Medicine, Krankenhaus Nordwest, Frankfurt am Main, Germany
/ Maren Messinger
  • Department of Laboratory Medicine, Krankenhaus Nordwest, Frankfurt am Main, Germany
/ Jo Linssen
  • Sysmex Scientific Department, Norderstedt, Germany
/ Marcus Thomé
  • Department of Laboratory Medicine, Krankenhaus Nordwest, Frankfurt am Main, Germany
/ Christian Thomas
  • Department of Urology and Pediatric Urology, Johannes Gutenberg University, Mainz, Germany
Published Online: 2005-10-19 | DOI: https://doi.org/10.1515/CCLM.2005.207

Abstract

The aims of this study were to diagnose iron-restricted erythropoiesis (functional iron deficiency) in patients with classic iron deficiency (ID), anemia of chronic disease (ACD) and the combined state of ID/ACD with the use of two hematological methods for the measurement of reticulocyte hemoglobinization. In comparison, the biochemical markers of iron status were determined. We studied 474 anemic patients admitted to hospital with a broad spectrum of diseases. We measured indicators of reticulocyte hemoglobinization. CHr was determined on an Advia 120 hematology analyzer. A Sysmex XE-2100 hematology analyzer was used to determine RET-Y, the forward scatter of fluorescence-labeled reticulocytes, which can also be expressed as the reticulocyte hemoglobin equivalent (RET-He), as well as RBC-Y, the forward scatter of fluorescence-labeled erythrocytes, which can be expressed as the erythrocyte hemoglobin equivalent. Ferritin, soluble transferrin receptor (sTfR) and the sTfR/log ferritin ratio (sTfR-F index) were used as biochemical markers. The comparison of RET-Y with CHr demonstrated an excellent curvilinear relationship between the two parameters. The normal reference range for Ret-Y was 1630–1860 arbitrary units (AU); mathematical transformation to RET-He gave a range of 28.2–35.7 pg. Correlations of biochemical iron markers with RET-He were as weak as with CHr in patients with ACD and acute phase response. In a diagnostic plot to identify iron status, RET-He could replace CHr without any loss of sensitivity or specificity. Patient mismatch analysis between RET-He and CHr in the diagnostic plot demonstrated agreement for 449 of 474 patients (94.4%). Patient specific anemia mismatches were 2.9–6.2%. According to our results, the indicators of reticulocyte hemoglobinization, RET-He and CHr, measure the same phenomenon. RET-He is as valuable as CHr for the diagnosis of iron-restricted erythropoiesis. The combination of RET-He and the sTfR-F index in a diagnostic plot offers an attractive tool for the evaluation of iron status and identification of the progression of ID.

Keywords: acute-phase response; anemia of chronic disease; functional iron deficiency; iron-restricted erythropoiesis; reticulocyte hemoglobin

References

  • 1.

    Cavill I. Functional iron deficiency. Blood 1993; 82:137.

  • 2.

    Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of anemia of chronic disease. Blood 1992; 80:1639–47.

  • 3.

    Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48:1066–76.

  • 4.

    Skikne BS. Circulating transferrin receptor assay – coming of age. Clin Chem 1998; 44:7–9.

  • 5.

    Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003; 329:9–22.

  • 6.

    Worwood M. Serum transferrin receptor assays and their application. Ann Clin Biochem 2002; 39:221–30. [Crossref]

  • 7.

    Baynes RD, Skikne BS, Cook JD. Circulating transferrin receptors and assessment of iron status. J Nutr Biochem 1994; 5:322–30. [Crossref]

  • 8.

    Punnonen K, Irjala K, Rajarnäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89:1052–7.

  • 9.

    Suominen P, Punnonen K, Rajarnäki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998; 92:2934–9.

  • 10.

    Malope BI, MacPhail AP, Alberts M, Hiss DC. The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status. Br J Haematol 2001; 115:84–9. [Crossref]

  • 11.

    Lee EJ, Park YJ, Lee HK, Kim BK. Soluble transferrin receptor (sTfR), ferritin and sTfR/log ferritin index in anemic patients with non-hematologic malignancy of chronic inflammation. Clin Chem 2002; 48:1118–21.

  • 12.

    Rimon E, Levy S, Sapir A, Gelzer G, Peled R, Ergas D, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med 2002; 162:445–9. [Crossref]

  • 13.

    Cermak J, Brabec V. Transferrin receptor-ferritin index: a useful parameter in differential diagnosis of iron deficiency and hyperplastic erythropoiesis. Eur J Haematol 1998; 61:210–2. [Crossref]

  • 14.

    Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faulbert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60:2406–11. [Crossref]

  • 15.

    Mittman N, Sreedhara R, Mushnick R, Chattopdadhyay J, Zelmanoviv D, Mehdi V, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30:912–22. [Crossref]

  • 16.

    Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. J Am Med Assoc 1999; 281:2225–30.

  • 17.

    Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99:1489–91. [Crossref]

  • 18.

    Noronha JF, Grotto HZ. Measurement of reticulocyte and red blood cell indices in patients with iron deficiency anemia and β-thalassemia minor. Clin Chem Lab Med 2005;195–7.

  • 19.

    Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998; 28:1–11. [Crossref]

  • 20.

    Buttarello M, Temporin V, Ceravolo R, Farina G, Bulian P. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100. Am J Clin Pathol 2004; 121:489–95.

  • 21.

    Briggs C, Rogers R, Thompson B, Machin SJ. New red cell parameters on the Sysmex XE-2100 as potential markers of functional iron deficiency. Infus Ther Transfus Med 2001; 28:256–62.

  • 22.

    Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Clin Biochem 1996; 34:517–20.

  • 23.

    Vernet M, Doyen C. Assessment of iron status with a new fully automated assay for transferrin receptor in human serum. Clin Chem Lab Med 2000; 38:437–42. [Crossref]

  • 24.

    d'Onofrio G, Chirillo R, Zini G, Caenaro G, Tommasi M, Micciuli G. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 85:818–23.

  • 25.

    Schoonjans F. MedCalc statistics for biomedical research. Mariakerke, Belgium: MedCalc Software, 1998:1–163.

  • 26.

    Brugnara C, Colella GM, Cremins J, Langley RC Jr, Schneider T, Rutherford CJ, et al. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994; 123:660–7.

  • 27.

    Franck S, Linssen J, Messinger M, Thomas L. Potential clinical utility of the RET-Y in iron-restricted erythropoiesis. Clin Chem 2004; 50:1240–2. [Crossref]

  • 28.

    Chuang CL, Liu RS, Wein YH, Huang TP, Tarng DC. Early prediction of response to intravenous iron supplementation by reticulocyte hemoglobin content and high fluorescence reticulocyte count in hemodialysis patients. Nephrol Dial Transplant 2003; 18:370–7. [Crossref]

  • 29.

    Thomas C, Kirschbaum A, Boehm D, Thomas L. The Diagnostic Plot – a concept for identifying different states of iron deficiency and monitoring the response to epoietin. Med Oncol 2005. In press.

  • 30.

    Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003; 49:1573–8. [Crossref]

  • 31.

    Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 2005; 11:14–23. [Crossref]

About the article

Corresponding author: Lothar Thomas, MD, Department of Laboratory Medicine, Krankenhaus Nordwest, Steinbacher Hohl 2-26, 60488 Frankfurt, Germany Phone: +49-69-76013252, Fax: +49-69-78 73 40,


Received: 2005-07-18

Accepted: 2005-08-30

Published Online: 2005-10-19

Published in Print: 2005-11-01



Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.207. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
Journal of Clinical Laboratory Analysis, 2016, Page n/a
[2]
M. Maconi, L. Cavalca, P. Danise, F. Cardarelli, and M. Brini
Scandinavian Journal of Clinical and Laboratory Investigation, 2009, Volume 69, Number 3, Page 365
[3]
Sarka Davidkova, Timothy D. Prestidge, Peter W. Reed, Tonya Kara, William Wong, and Chanel Prestidge
Pediatric Nephrology, 2015
[4]
M. Basora Macaya and E. Bisbe Vives
Revista Española de Anestesiología y Reanimación, 2015, Volume 62, Page 19
[6]
M. Basora, M.J. Colomina, M. Tio, L. Mora, G. Sánchez-Etayo, F. Salazar, E. Ciércoles, M. Paños, E. Guerrero, and R. Berge
Revista Española de Anestesiología y Reanimación (English Edition), 2015, Volume 62, Number 6, Page 313
[7]
M. Basora, M.J. Colomina, M. Tio, L. Mora, G. Sánchez-Etayo, F. Salazar, E. Ciércoles, M. Paños, E. Guerrero, and R. Berge
Revista Española de Anestesiología y Reanimación, 2015, Volume 62, Number 6, Page 313
[8]
Edward C.C. Wong
Clinics in Laboratory Medicine, 2015, Volume 35, Number 1, Page 165
[10]
Elisa Piva, Carlo Brugnara, Federica Spolaore, and Mario Plebani
Clinics in Laboratory Medicine, 2015, Volume 35, Number 1, Page 133
[11]
Tadashi Kuji, Yoshiyuki Toya, Tetsuya Fujikawa, Midori Kakimoto-Shino, Masahiro Nishihara, Kazuhiko Shibata, Kouichi Tamura, Nobuhito Hirawa, Hidehisa Satta, Sei-ichi Kawata, Naoaki Kouguchi, and Satoshi Umemura
Therapeutic Apheresis and Dialysis, 2015, Volume 19, Number 2, Page 131
[12]
Sigismond Lasocki, Nicolas Chudeau, Thibaut Papet, Deborah Tartiere, Antoine Roquilly, Laurence Carlier, Olivier Mimoz, Philippe Seguin, Yannick Malledant, Karim Asehnoune, and Jean Hamel
Critical Care, 2014, Volume 18, Number 5, Page 542
[13]
Lázaro Alessandro Soares Nunes, Helena Zerlotti W. Grotto, René Brenzikofer, and Denise Vaz Macedo
BioMed Research International, 2014, Volume 2014, Page 1
[14]
D. Wayne Thomas, Rod F. Hinchliffe, Carol Briggs, Iain C. Macdougall, Tim Littlewood, and Ivor Cavill
British Journal of Haematology, 2013, Volume 161, Number 5, Page 639
[15]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
BioMed Research International, 2013, Volume 2013, Page 1
[16]
Tor-Arne Hagve, Kristin Lilleholt, and Marianne Svendsen
Tidsskrift for Den norske legeforening, 2013, Volume 133, Number 2, Page 161
[17]
V. Osta, M. S. Caldirola, M. Fernandez, M. I. Marcone, G. Tissera, S. Pennesi, and C. Ayuso
International Journal of Laboratory Hematology, 2013, Volume 35, Number 4, Page 400
[18]
Aya Eguchi, Takahiro Mochizuki, Misao Tsukada, Koji Kataoka, Yukio Hamaguchi, Shinichiro Oguni, Kosaku Nitta, and Ken Tsuchiya
International Journal of Nephrology, 2012, Volume 2012, Page 1
[19]
Etienne Joosten, Pieter Lioen, Caroline Brusselmans, Christophe Indevuyst, and Nancy Boeckx
European Journal of Internal Medicine, 2013, Volume 24, Number 1, Page 63
[20]
E. Urrechaga, L. Borque, and J. F. Escanero
International Journal of Laboratory Hematology, 2013, Volume 35, Number 2, Page 144
[21]
ANGEL F. REMACHA, M. PILAR SARDÁ, M. CRISTINA FERNÁNDEZ, and M. JOSÉ MURGA
Transfusion Alternatives in Transfusion Medicine, 2012, Volume 12, Number 3-4, Page 95
[22]
Walter Reinisch, Michael Staun, Sunil Bhandari, and Manuel Muñoz
Journal of Crohn's and Colitis, 2013, Volume 7, Number 6, Page 429
[23]
Å. A. Sudmann, A. Piehler, and P. Urdal
International Journal of Laboratory Hematology, 2012, Volume 34, Number 6, Page 605
[25]
E. URRECHAGA, M. UNCETA, L. BORQUE, and J. F. ESCANERO
International Journal of Laboratory Hematology, 2012, Volume 34, Number 1, Page 47
[27]
M. HUR, J.-H. CHO, H. KIM, M.-H. HONG, H.-W. MOON, Y.-M. YUN, and J. Q. KIM
International Journal of Laboratory Hematology, 2011, Volume 33, Number 4, Page 434
[28]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
Anemia, 2010, Volume 2010, Page 1
[30]
Eloísa Urrechaga, Luís Borque, and Jesús F. Escanero
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 11
[31]
E. URRECHAGA, L. BORQUE, and J. F. ESCANERO
International Journal of Laboratory Hematology, 2011, Volume 33, Number 1, Page 37
[32]
S. JAYARANEE and P. STHANESHWAR
International Journal of Laboratory Hematology, 2010, Volume 32, Number 5, Page 512
[33]
M. P. G. LEERS, J. F. W. KEUREN, and W. P. OOSTERHUIS
International Journal of Laboratory Hematology, 2010, Volume 32, Number 6p2, Page 572
[34]
Mariacaterina Maconi, Debora Formisano, Leandra Cavalca, Alessandro Rolfo, Simona Cardaropoli, and Paolo Danise
Laboratory Hematology, 2010, Volume 16, Number 1, Page 3
[35]
N. MIWA, T. AKIBA, N. KIMATA, Y. HAMAGUCHI, Y. ARAKAWA, T. TAMURA, K. NITTA, and K. TSUCHIYA
International Journal of Laboratory Hematology, 2010, Volume 32, Number 2, Page 248
[36]
E. URRECHAGA
International Journal of Laboratory Hematology, 2009, Volume 31, Number 6, Page 623
[37]
Quirijn de Mast, Edmee C. van Dongen-Lases, Dorine W. Swinkels, An-Emmie Nieman, Meta Roestenberg, Pierre Druilhe, Theo A. Arens, Adrian J. Luty, Cornelis C. Hermsen, Robert W. Sauerwein, and Andre J. van der Ven
British Journal of Haematology, 2009, Volume 145, Number 5, Page 657
[38]
C. BRIGGS
International Journal of Laboratory Hematology, 2009, Volume 31, Number 3, Page 277
[39]
V. Nadarajan, P. Sthaneshwar, and G. I. Eow
Transfusion Medicine, 2008, Volume 18, Number 3, Page 184
[40]
Alan E. Mast, Morey A. Blinder, and Dennis J. Dietzen
American Journal of Hematology, 2008, Volume 83, Number 4, Page 307
[41]
Mari Ervasti, Sanna Kotisaari, Seppo Heinonen, and Kari Punnonen
European Journal of Haematology, 2007, Volume 79, Number 6, Page 539
[42]
C. BRUGNARA, B. SCHILLER, and J. MORAN
Clinical and Laboratory Haematology, 2006, Volume 28, Number 5, Page 303

Comments (0)

Please log in or register to comment.
Log in